Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome Journal:Signal transduction and targeted therapy | 29-Aug-2022 | ||
Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes Journal:Rheumatology and Immunology Research | 1-Mar-2022 |